Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Loss of RBM-26 causes mitochondria dysfunction in PLM. حسب Tamjid A. Chowdhury (14149846)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Loss of RBM-26 function causes a reduction in the density of mitochondria in the PLM axon. حسب Tamjid A. Chowdhury (14149846)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. حسب Tamjid A. Chowdhury (14149846)

S8 File - حسب Martha R. Smith (20410184)

"…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…"

Study populations of included studies. حسب Martha R. Smith (20410184)

"…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…"

Future research directions. حسب Martha R. Smith (20410184)

"…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…"

PRISMA flow diagram. حسب Martha R. Smith (20410184)

"…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…"

S9 File - حسب Martha R. Smith (20410184)

"…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…"

S7 File - حسب Martha R. Smith (20410184)

"…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…"

Participant characteristics of included studies. حسب Martha R. Smith (20410184)

"…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…"

The contemporary, long-term seasonality in inundation over the whole of the Amazon basin. حسب Nic Gedney (19762301)

Contemporary mean inundation fraction in the Amazon basin. حسب Nic Gedney (19762301)

S1 File - حسب Jacob P. Rastas (20642173)

"…Overall, when warming treatments and time points were combined, the decrease in rectal temperature from baseline was significantly greater with ACE than DEX (P < 0.05). …"

Raw data. حسب Saeedeh Abbasi (9423189)

"…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …"

Data. حسب Saeedeh Abbasi (9423189)

"…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …"

Patient characteristics before and after propensity score matching. حسب Anna D. Ware (19688153)

الموضوعات:

Unadjusted and adjusted odds ratios (95% confidence interval) for associations between patients who were prescribed aspirin at baseline and the occurrence of post-COVID-19 acute th... حسب Anna D. Ware (19688153)

الموضوعات: